CD14/TLR4 Priming Potentially Recalibrates and Exerts Anti-tumor Efficacy in Tumor Associated Macrophages in a Mouse Model of Pancreatic Carcinoma

Overview

Journal Sci Rep

Specialty Science

Date 2016 Aug 12

PMID 27511884

Citations 20

Authors

Hridayesh Prakash

Vinod Nadella

Sandhya Singh

Hubertus Schmitz-Winnenthal

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is the fourth major cause of cancer related deaths in the world and 5 year survival is below 5%. Among various tumor directed therapies, stimulation of Toll-like receptors (TLR) has shown promising effects in various tumor models. However, pancreatic cancer cells frequently express these receptors themselves and their stimulation (TLR 2 and/or 4 particularly) within tumor microenvironment is known to potentially enhance tumor cell proliferation and cancer progression. Consistent stimulation of tumor associated macrophages (TAMs), in particular with tumor derived TLR ligand within the tumor microenvironment promotes cancer related inflammation, which is sterile, non-immunogenic and carcinogenic in nature. In view of this, recalibrating of TAM has the potential to induce immunogenic inflammation. Consistent with this, we provide experimental evidence for the first time in this study that priming of TAMs with TLR4 ligend (LPS) alone or in combination with IFN-γ not only recalibrates pancreatic tumor cells induced M2 polarization, but also confers anti-tumor potential in TAMs. Most interestingly, reduced tumor growth in macrophage depleted animals suggests that macrophage directed approaches are important for the management of pancreatic tumors.

Citing Articles

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine.

Nagaraju G, Saddala M, Foote J, Khaliq A, Masood A, Golivi Y Cell Rep Med. 2024; 6(1):101881.

PMID: 39730001 PMC: 11866435. DOI: 10.1016/j.xcrm.2024.101881.

Lipopolysaccharide induces CCL2 through TLR4 signaling and promotes esophageal squamous cell carcinoma cell proliferation.

Sasamori R, Sato Y, Nomura K, Wakita A, Nagaki Y, Kemuriyama K Am J Cancer Res. 2024; 14(7):3497-3512.

PMID: 39113860 PMC: 11301279. DOI: 10.62347/EIKE6128.

Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma.

Waldron R, Lugea A, Chang H, Su H, Quiros C, Lewis M Cancers (Basel). 2024; 16(8).

PMID: 38672675 PMC: 11048773. DOI: 10.3390/cancers16081593.

Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesis.

Prasad R, Mishra N, Kant R, Fox J, Shoemaker R, Agarwal C Mol Carcinog. 2024; 63(6):1188-1204.

PMID: 38506376 PMC: 11096027. DOI: 10.1002/mc.23718.

Role of CD14 in human disease.

Sharygin D, Koniaris L, Wells C, Zimmers T, Hamidi T Immunology. 2023; 169(3):260-270.

PMID: 36840585 PMC: 10591340. DOI: 10.1111/imm.13634.

References

Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K . M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas. 2012; 42(1):155-9. DOI: 10.1097/MPA.0b013e318254f2d1. View

Ye S, Xu H, Jin J, Yang M, Wang C, Yu Y . The E3 ubiquitin ligase neuregulin receptor degradation protein 1 (Nrdp1) promotes M2 macrophage polarization by ubiquitinating and activating transcription factor CCAAT/enhancer-binding Protein β (C/EBPβ). J Biol Chem. 2012; 287(32):26740-8. PMC: 3411012. DOI: 10.1074/jbc.M112.383265. View

Schwacha M, Chaudry I, Alexander M . Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock. 2003; 20(6):529-35. DOI: 10.1097/01.shk.0000095059.62263.56. View

Corbett T, Roberts B, Leopold W, Peckham J, WILKOFF L, Griswold Jr D . Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res. 1984; 44(2):717-26. View

Siveen K, Kuttan G . Role of macrophages in tumour progression. Immunol Lett. 2009; 123(2):97-102. DOI: 10.1016/j.imlet.2009.02.011. View

Lapteva N, Seethammagari M, Hanks B, Jiang J, Levitt J, Slawin K . Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation. Cancer Res. 2007; 67(21):10528-37. DOI: 10.1158/0008-5472.CAN-07-0833. View

Ohri C, Shikotra A, Green R, Waller D, Bradding P . Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J. 2009; 33(1):118-26. DOI: 10.1183/09031936.00065708. View

Ma J, Liu L, Che G, Yu N, Dai F, You Z . The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010; 10:112. PMC: 2851690. DOI: 10.1186/1471-2407-10-112. View

Maeda Y, Echizen K, Oshima H, Yu L, Sakulsak N, Hirose O . Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment. Cancer Prev Res (Phila). 2016; 9(3):253-63. DOI: 10.1158/1940-6207.CAPR-15-0315. View

10.

Gazzaniga S, Bravo A, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A . Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol. 2007; 127(8):2031-41. DOI: 10.1038/sj.jid.5700827. View

11.

Benoit M, Desnues B, Mege J . Macrophage polarization in bacterial infections. J Immunol. 2008; 181(6):3733-9. DOI: 10.4049/jimmunol.181.6.3733. View

12.

Teich N, Mossner J . Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008; 22(1):115-30. DOI: 10.1016/j.bpg.2007.10.019. View

13.

Jura N, Archer H, Bar-Sagi D . Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Res. 2005; 15(1):72-7. DOI: 10.1038/sj.cr.7290269. View

14.

Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L . Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol. 2010; 185(1):642-52. DOI: 10.4049/jimmunol.1000413. View

15.

Tachado S, Li X, Bole M, Swan K, Anandaiah A, Patel N . MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons. Blood. 2010; 115(17):3606-15. PMC: 2867269. DOI: 10.1182/blood-2009-10-250787. View

16.

Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F . Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2009; 167(2):e211-9. DOI: 10.1016/j.jss.2009.05.026. View

17.

Tsan M . Toll-like receptors, inflammation and cancer. Semin Cancer Biol. 2005; 16(1):32-7. DOI: 10.1016/j.semcancer.2005.07.004. View

18.

Moreno C, Merino J, Ramirez N, Echeverria A, Pastor F, Sanchez-Ibarrola A . Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14. Microbes Infect. 2004; 6(11):990-5. DOI: 10.1016/j.micinf.2004.05.010. View

19.

Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F . Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol. 2004; 57(6):630-6. PMC: 1770337. DOI: 10.1136/jcp.2003.014498. View

20.

Kim B, Spinner D, Kascsak R, Park S, Cho I, Schuller-Levis G . Inflammatory mediators are inhibited by a taurine metabolite in CpG oligodeoxynucleotide and IFN-r activated macrophage cell line. J Drugs Dermatol. 2013; 12(5):551-7. View